Silvester Jocelyn A, Graff Lesley A, Rigaux Lisa, Bernstein Charles N, Leffler Daniel A, Kelly Ciarán P, Walker John R, Duerksen Donald R
Rady College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Dig Dis Sci. 2017 Sep;62(9):2449-2454. doi: 10.1007/s10620-017-4666-z. Epub 2017 Jul 7.
Celiac disease and functional intestinal disorders may overlap, yet the natural history of functional symptoms in patients with celiac disease is unknown.
To investigate the prevalence of irritable bowel syndrome (IBS), functional dyspepsia (FD), and functional bloating (FB) symptoms among patients with celiac disease at diagnosis and during the first year of a gluten-free diet.
Adults with a new diagnosis of celiac disease were surveyed at baseline, 6 months and 1 year using standardized measures for intestinal symptoms [Rome III diagnostic questionnaire and celiac symptom index (CSI)] and gluten-free diet adherence [gluten-free eating assessment tool (GF-EAT) and celiac diet adherence test].
At diagnosis, two-thirds fulfilled Rome III diagnostic questionnaire symptom criteria for IBS (52%), functional dyspepsia (27%), and/or functional bloating (9%). One year post-diagnosis, there was high adherence to a gluten-free diet as 93% reported gluten exposure less than once per month on the GF-EAT and only 8% had ongoing celiac disease symptoms (CSI score >45). The rates of those meeting IBS (22%) and functional dyspepsia (8%) symptom criteria both decreased significantly on a gluten-free diet. The prevalence of functional symptoms (any of IBS, FD or FB) at 1 year was 47%.
Long-term follow-up of patients with celiac disease is necessary because many patients with celiac disease who are adherent to a gluten-free diet have persistent gastrointestinal symptoms.
乳糜泻与功能性肠病可能存在重叠,但乳糜泻患者功能性症状的自然病程尚不清楚。
调查乳糜泻患者在诊断时及无麸质饮食的第一年中肠易激综合征(IBS)、功能性消化不良(FD)和功能性腹胀(FB)症状的患病率。
对新诊断为乳糜泻的成年人在基线、6个月和1年时进行调查,采用肠道症状的标准化测量方法[罗马III诊断问卷和乳糜泻症状指数(CSI)]以及无麸质饮食依从性[无麸质饮食评估工具(GF-EAT)和乳糜泻饮食依从性测试]。
诊断时,三分之二的患者符合罗马III诊断问卷中IBS(52%)、功能性消化不良(27%)和/或功能性腹胀(9%)的症状标准。诊断后一年,无麸质饮食的依从性较高,因为93%的患者在GF-EAT上报告每月麸质暴露少于一次,只有8%的患者有持续的乳糜泻症状(CSI评分>45)。无麸质饮食时,符合IBS(22%)和功能性消化不良(8%)症状标准的患者比例均显著下降。1年时功能性症状(IBS、FD或FB中的任何一种)的患病率为47%。
乳糜泻患者需要长期随访,因为许多坚持无麸质饮食的乳糜泻患者仍有持续的胃肠道症状。